An efficient method for N-acetyl-d-neuraminic acid production using coupled bacterial cells with a safe temperature-induced system
- 4 November 2009
- journal article
- biotechnological products-and-process-engineering
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 86 (2) , 481-489
Abstract
N-Acetyl-d-neuraminic acid (Neu5Ac) is a precursor for producing many pharmaceutical drugs such as zanamivir which have been used in clinical trials to treat and prevent the infection with influenza virus, such as the avian influenza virus H5N1 and the current 2009 H1N1. Two recombinant Escherichia coli strains capable of expressing N-acetyl-d-glucosamine 2-epimerase and N-acetyl-d-neuraminic acid aldolase were constructed based on a highly efficient temperature-responsive expression system which is safe compared to chemical-induced systems and coupled in Neu5Ac production. Carbon sources were optimized for Neu5Ac production, and the concentration effects of carbon sources on the production were investigated. With 2,200 mM pyruvate as carbon source and substrate, 61.9 mM (19.1 g l−1) Neu5Ac was produced from 200 mM N-acetyl-d-glucosamine (GlcNAc) in 36 h by the coupled cells. Our Neu5Ac biosynthetic process is favorable compared with natural product extraction, chemical synthesis, or even many other biocatalysis processes.Keywords
This publication has 29 references indexed in Scilit:
- Comparison of the Effectiveness of Zanamivir and Oseltamivir against Influenza A/H1N1, A/H3N2, and BClinical Infectious Diseases, 2009
- Effect of different carbon sources on central metabolic fluxes and the recombinant production of a hydrolase from Thermobifida fusca in Bacillus megateriumJournal of Biotechnology, 2007
- Production of N-acetyl-d-neuraminic acid by recombinant whole cells expressing Anabaena sp. CH1 N-acetyl-d-glucosamine 2-epimerase and Escherichia coli N-acetyl-d-neuraminic acid lyaseJournal of Biotechnology, 2007
- Development of an ion‐pair HPLC method for investigation of energy charge changes in cerebral ischemia of mice and hypoxia of Neuro‐2a cell lineBiomedical Chromatography, 2007
- Influenza Pandemics of the 20th CenturyEmerging Infectious Diseases, 2006
- Production of N-acetylneuraminic acid from N-acetylglucosamine and pyruvate using recombinant human renin binding protein and sialic acid aldolase in one potEnzyme and Microbial Technology, 2004
- The Complete Genome Sequence of Escherichia coli K-12Science, 1997
- Plasmid pMTL153: a high copy number version of pAT153 and its use to obtain high expression of the Pseudomonas carboxypeptidase G2 geneApplied Microbiology and Biotechnology, 1988
- Physical change in cytoplasmic messenger ribonucleoproteins in cells treated with inhibitors of mRNA transcription.Molecular and Cellular Biology, 1984
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976